Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRT and Small Artery Function
NCT00564031Phase 3Completed
- Sponsor
- Karolinska University Hospital
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of estradiol and medroxyprogesterone acetate in menopause (4 arms), sponsored by Karolinska University Hospital. Primary endpoint: Endothelium-dependent dilatation at 3 months. Started Jan 2003; status: completed.
02
Drugs
estradiolmedroxyprogesterone acetate
03
Conditions
menopause
Beyond the preview
Go deeper on NCT00564031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00564031.